Cargando…
Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective study
BACKGROUND: Septic shock is the most feared complication of chemotherapy-induced febrile neutropenia. So far, there are no robust biomarkers that can stratify patients to the risk of sepsis complications. The VEGF-A axis is involved in the control of microvascular permeability and has been involved...
Autores principales: | Alves, Brunna E, Montalvao, Silmara AL, Aranha, Francisco JP, Lorand-Metze, Irene, De Souza, Carmino A, Annichino-Bizzacchi, Joyce M, De Paula, Erich V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058017/ https://www.ncbi.nlm.nih.gov/pubmed/21371321 http://dx.doi.org/10.1186/1479-5876-9-23 |
Ejemplares similares
-
Imbalances in serum angiopoietin concentrations are early predictors of septic shock development in patients with post chemotherapy febrile neutropenia
por: Alves, Brunna E, et al.
Publicado: (2010) -
A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia
por: Luz Fiusa, Maiara Marx, et al.
Publicado: (2013) -
VEGF and sFLT-1 in serum of PIH patients and effects on the foetus
por: Tang, Yanhong, et al.
Publicado: (2019) -
Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa
por: Wang, Na, et al.
Publicado: (2021) -
The Soluble VEGF Receptor sFlt-1 Contributes to Impaired Neovascularization in Aged Mice
por: Zhao, Guangxian, et al.
Publicado: (2017)